Cargando…

Assessment of geographic access to monoclonal antibodies in the United States

Using spatial modeling techniques, we highlight disparities in access to monoclonal antibodies (mAbs) used to treat COVID-19 patients. Fifteen million individuals in the United States must travel over 30 min to access mAbs. Areas with lower COVID-19 vaccination rates have worse access to essential C...

Descripción completa

Detalles Bibliográficos
Autores principales: Rader, Benjamin, Whaley, Christopher M, Rogers, Wesley S, Brownstein, Professor John S, Cantor, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155997/
https://www.ncbi.nlm.nih.gov/pubmed/35244695
http://dx.doi.org/10.1093/jtm/taac018
_version_ 1784718358704291840
author Rader, Benjamin
Whaley, Christopher M
Rogers, Wesley S
Brownstein, Professor John S
Cantor, Jonathan
author_facet Rader, Benjamin
Whaley, Christopher M
Rogers, Wesley S
Brownstein, Professor John S
Cantor, Jonathan
author_sort Rader, Benjamin
collection PubMed
description Using spatial modeling techniques, we highlight disparities in access to monoclonal antibodies (mAbs) used to treat COVID-19 patients. Fifteen million individuals in the United States must travel over 30 min to access mAbs. Areas with lower COVID-19 vaccination rates have worse access to essential COVID-19 therapeutics.
format Online
Article
Text
id pubmed-9155997
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91559972022-06-04 Assessment of geographic access to monoclonal antibodies in the United States Rader, Benjamin Whaley, Christopher M Rogers, Wesley S Brownstein, Professor John S Cantor, Jonathan J Travel Med Research Letter Using spatial modeling techniques, we highlight disparities in access to monoclonal antibodies (mAbs) used to treat COVID-19 patients. Fifteen million individuals in the United States must travel over 30 min to access mAbs. Areas with lower COVID-19 vaccination rates have worse access to essential COVID-19 therapeutics. Oxford University Press 2022-03-04 /pmc/articles/PMC9155997/ /pubmed/35244695 http://dx.doi.org/10.1093/jtm/taac018 Text en © International Society of Travel Medicine 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Letter
Rader, Benjamin
Whaley, Christopher M
Rogers, Wesley S
Brownstein, Professor John S
Cantor, Jonathan
Assessment of geographic access to monoclonal antibodies in the United States
title Assessment of geographic access to monoclonal antibodies in the United States
title_full Assessment of geographic access to monoclonal antibodies in the United States
title_fullStr Assessment of geographic access to monoclonal antibodies in the United States
title_full_unstemmed Assessment of geographic access to monoclonal antibodies in the United States
title_short Assessment of geographic access to monoclonal antibodies in the United States
title_sort assessment of geographic access to monoclonal antibodies in the united states
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155997/
https://www.ncbi.nlm.nih.gov/pubmed/35244695
http://dx.doi.org/10.1093/jtm/taac018
work_keys_str_mv AT raderbenjamin assessmentofgeographicaccesstomonoclonalantibodiesintheunitedstates
AT whaleychristopherm assessmentofgeographicaccesstomonoclonalantibodiesintheunitedstates
AT rogerswesleys assessmentofgeographicaccesstomonoclonalantibodiesintheunitedstates
AT brownsteinprofessorjohns assessmentofgeographicaccesstomonoclonalantibodiesintheunitedstates
AT cantorjonathan assessmentofgeographicaccesstomonoclonalantibodiesintheunitedstates